Drug Shortage Report for NUCYNTA IR
| Report ID | 179899 |
| Drug Identification Number | 02378272 |
| Brand name | NUCYNTA IR |
| Common or Proper name | TAPENTADOL |
| Company Name | ENDO VENTURES LTD. |
| Market Status | MARKETED |
| Active Ingredient(s) | TAPENTADOL |
| Strength(s) | 50MG |
| Dosage form(s) | TABLET (IMMEDIATE RELEASE) |
| Route of administration | ORAL ORAL |
| Packaging size | 100 tabs |
| ATC code | N02AX |
| ATC description | OPIOIDS |
| Reason for shortage | Delay in shipping of the drug. |
| Anticipated start date | 2023-01-05 |
| Actual start date | 2023-02-15 |
| Estimated end date | 2023-02-20 |
| Actual end date | 2023-02-20 |
| Shortage status | Resolved |
| Updated date | 2023-05-02 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 1ST FLOOR, MINERVA HOUSE, SIMMONSCOURT ROAD BALLSBRIDGE, DUBLIN IRELAND D04 H9P8 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v9 | 2023-05-02 | French | Compare |
| v8 | 2023-05-02 | English | Compare |
| v7 | 2023-02-21 | French | Compare |
| v6 | 2023-02-21 | English | Compare |
| v5 | 2023-02-20 | French | Compare |
| v4 | 2023-02-20 | English | Compare |
| v3 | 2023-01-06 | English | Compare |
| v2 | 2023-01-05 | French | Compare |
| v1 | 2023-01-05 | English | Compare |
Showing 1 to 9 of 9